In this issue:
Allogenic HCT services during the COVID-19 pandemic
Malignant neoplasms of the GI tract after BMT
Ibrutinib for first-line treatment of chronic GvHD
Haploidentical versus matched unrelated donors for patients with ALL
HSC boost for persistent neutropenia
ASCT for relapsed follicular lymphoma
DPd followed by ASCT for RRMM
Safety of ASCT in dialysisdependent myeloma patients
Please login below to download this issue (PDF)